Finally, we show that the same pharmacological strategies that are efficacious in improving stroke recovery through pre-stroke weight loss (via GLP-1R/NPY2R) can additionally provide acute neuroprotective effects post-stroke, independently of weight loss induction. The gene discussed is GLP1R; the disease is stroke disorder.